453 related articles for article (PubMed ID: 31057055)
21. Lead Optimization Studies Towards Finding NS2B/NS3 Protease Targetspecific Inhibitors as Potential Anti-dengue Drug-like Compounds.
Gurusamy M; Abdul JF
Curr Drug Discov Technol; 2019; 16(3):307-314. PubMed ID: 29984660
[TBL] [Abstract][Full Text] [Related]
22. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
Zaka M; Abbasi BH; Durdagi S
J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
[TBL] [Abstract][Full Text] [Related]
23. Identification of potential inhibitors for HCV NS3 genotype 4a by combining protein-ligand interaction fingerprint, 3D pharmacophore, docking, and dynamic simulation.
El-Hasab MAE; El-Bastawissy EE; El-Moselhy TF
J Biomol Struct Dyn; 2018 May; 36(7):1713-1727. PubMed ID: 28531373
[TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor potentially stable conformations from molecular dynamics as a structure-based pharmacophore model for mapping, screening, and identifying ligands-a new paradigm shift in pharmacophore screening.
Shanmugarajan D; David C
J Biomol Struct Dyn; 2023 Jul; 41(11):4939-4948. PubMed ID: 35543232
[TBL] [Abstract][Full Text] [Related]
25. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
[TBL] [Abstract][Full Text] [Related]
26. Ligand based 3D-QSAR model, pharmacophore, molecular docking and ADME to identify potential fibroblast growth factor receptor 1 inhibitors.
Huang L; Wu X; Fu X; Wang H; Tang B; Xiao Y; Zhou C; Zhao Z; Wan Y; Chen H; Tang Z; Yao H; Shan Z; Bu T
J Biomol Struct Dyn; 2022 Oct; 40(16):7584-7597. PubMed ID: 33734039
[TBL] [Abstract][Full Text] [Related]
27. Identification of potential inhibitors for HCV NS5b of genotype 4a by combining dynamic simulation, protein-ligand interaction fingerprint, 3D pharmacophore, docking and 3D QSAR.
El-Hassab MAE; El-Bastawissy EE; El-Moselhy TF
J Biomol Struct Dyn; 2020 Sep; 38(15):4521-4535. PubMed ID: 31647392
[TBL] [Abstract][Full Text] [Related]
28. Antiviral activity of astragaloside II, astragaloside III and astragaloside IV compounds against dengue virus: Computational docking and in vitro studies.
Indu P; Arunagirinathan N; Rameshkumar MR; Sangeetha K; Divyadarshini A; Rajarajan S
Microb Pathog; 2021 Mar; 152():104563. PubMed ID: 33098932
[TBL] [Abstract][Full Text] [Related]
29. Ligand-based pharmacophore modeling and QSAR approach to identify potential dengue protease inhibitors.
Poola AA; Prabhu PS; Murthy TPK; Murahari M; Krishna S; Samantaray M; Ramaswamy A
Front Mol Biosci; 2023; 10():1106128. PubMed ID: 36911525
[TBL] [Abstract][Full Text] [Related]
30. An insight into selective and potent inhibition of histone deacetylase 8 through induced-fit docking, pharmacophore modeling and QSAR studies.
Kashyap K; Kakkar R
J Biomol Struct Dyn; 2020 Jan; 38(1):48-65. PubMed ID: 30633630
[TBL] [Abstract][Full Text] [Related]
31.
Joshi T; Sharma P; Joshi T; Chandra S
J Biomol Struct Dyn; 2020 Aug; 38(12):3544-3562. PubMed ID: 31524074
[TBL] [Abstract][Full Text] [Related]
32. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
[TBL] [Abstract][Full Text] [Related]
33. Discovery of potent Camkk1 kinase inhibitors through e-pharmacophore and molecular screening approaches.
Prajisha J; Biswal J; Jeyakanthan J
J Biomol Struct Dyn; 2022 Apr; 40(6):2740-2756. PubMed ID: 33155526
[TBL] [Abstract][Full Text] [Related]
34. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
Dwivedi VD; Tripathi IP; Mishra SK
J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
[TBL] [Abstract][Full Text] [Related]
35. Pharmacophore-based virtual screening and
Roney M; Huq AKMM; Issahaku AR; Soliman MES; Hossain MS; Mustafa AH; Islam MA; Dubey A; Tufail A; Mohd Aluwi MFF; Tajuddin SN
J Biomol Struct Dyn; 2023; 41(21):12186-12203. PubMed ID: 36645141
[TBL] [Abstract][Full Text] [Related]
36. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
[TBL] [Abstract][Full Text] [Related]
37. Discovery of novel VEGFR2-TK inhibitors by phthalimide pharmacophore based virtual screening, molecular docking, MD simulation and DFT.
Matore BW; Roy PP; Singh J
J Biomol Struct Dyn; 2023; 41(22):13056-13077. PubMed ID: 36775656
[TBL] [Abstract][Full Text] [Related]
38. Modification of
Tambunan USF; Nasution MAF; Azhima F; Parikesit AA; Toepak EP; Idrus S; Kerami D
Drug Target Insights; 2017; 11():1177392817701726. PubMed ID: 28469408
[TBL] [Abstract][Full Text] [Related]
39. Natural chemical entities from
Navyashree V; Kant K; Kumar A
J Biomol Struct Dyn; 2021 Mar; 39(4):1404-1416. PubMed ID: 32072856
[TBL] [Abstract][Full Text] [Related]
40. Compounds Identified from Marine Mangrove Plant
Aljahdali MO; Molla MHR; Ahammad F
Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33925208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]